FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
Key Details
- 1FDA has approved the Targeted Real-Time Early Warning System for sepsis from researchers at Johns Hopkins, commercialized by Bayesian Health.
- 2The AI analyzes electronic health records to identify sepsis earlier than doctors traditionally can—often by 2 to 48 hours.
- 3System deployment in multiple hospitals reduced sepsis mortality rates by 18% and shortened hospital stays.
- 4Sepsis leads to over 250,000 deaths annually in the US and accounts for one in three in-hospital deaths.
- 5FDA clearance enables hospitals to bill Medicare/Medicaid under the New Technology Add-on Payment program.
- 6The solution demonstrates robust clinical AI integration with real-world hospital data for actionable guidance.
Why It Matters
The FDA's clearance of this early sepsis warning system marks a significant milestone for clinical AI adoption, demonstrating real-world impact on patient outcomes. It highlights how machine learning can augment clinical vigilance and potentially become part of standard hospital care, informing future radiology-AI solutions.
Source
EurekAlert
Related News
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
AI Analyzes 66,000 MRI Scans to Map Body Composition Risks
Researchers used AI to analyze over 66,000 whole-body MRI scans, creating a detailed body composition reference map linked to health risks.